메뉴 건너뛰기
소속 기관 / 학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
고객센터 ENG
주제분류

논문 기본 정보

저자정보
출처
Springer Science and Business Media LLC Scientific Reports 13(1)
오류 신고하기
표지

검색

    초록·키워드

    Decreased total CO<sub>2</sub> (tCO<sub>2</sub>) is significantly associated with all-cause mortality in critically ill patients. Because of a lack of data to evaluate the impact of tCO<sub>2</sub> in patients with COVID-19, we assessed the impact of tCO<sub>2</sub> on all-cause mortality in this study. We retrospectively reviewed the data of hospitalized patients with COVID-19 in two Korean referral hospitals between February 2020 and September 2021. The primary outcome was in-hospital mortality. We assessed the impact of tCO<sub>2</sub> as a continuous variable on mortality using the Cox-proportional hazard model. In addition, we evaluated the relative factors associated with tCO<sub>2</sub> ≤ 22 mmol/L using logistic regression analysis. In 4,423 patients included, the mean tCO<sub>2</sub> was 24.8 ± 3.0 mmol/L, and 17.9% of patients with tCO<sub>2</sub> ≤ 22 mmol/L. An increase in mmol/L of tCO<sub>2</sub> decreased the risk of all-cause mortality by 4.8% after adjustment for age, sex, comorbidities, and laboratory values. Based on 22 mmol/L of tCO<sub>2</sub>, the risk of mortality was 1.7 times higher than that in patients with lower tCO<sub>2</sub>. This result was maintained in the analysis using a cutoff value of tCO<sub>2</sub> 24 mmol/L. Higher white blood cell count; lower hemoglobin, serum calcium, and eGFR; and higher uric acid, and aspartate aminotransferase were significantly associated with a tCO<sub>2</sub> value ≤ 22 mmol/L. Decreased tCO<sub>2</sub> significantly increased the risk of all-cause mortality in patients with COVID-19. Monitoring of tCO<sub>2</sub> could be a good indicator to predict prognosis and it needs to be appropriately managed in patients with specific conditions.

    본문·목차

    최근 본 자료 전체보기